The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM
Open accessAbstract
The serine/threonine protein kinase ATM signals to cell cycle and DNA repair components by phosphorylating downstream targets such as p53, CHK2, NBS1, and BRCA1. Mutation of ATM occurs in the human autosomal recessive disorder ataxia-telangiectasia, which is characterized by hypersensitivity to ionizing radiation and a failure of cells to arrest the cell cycle after the induction of DNA double-strand breaks. It has thus been proposed that ATM inhibition would cause cellular radio- and chemosensitization. Through screening a small molecule compound library developed for the phosphatidylinositol 3'-kinase-like kinase family, we identified an ATP-competitive inhibitor, 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one (KU-55933), that inhibits ATM with an IC(50) of 13 nmol/L and a Ki of 2.2 nmol/L. KU-55933 shows specificity with respect to inhibition of other phosphatidylinositol 3'-kinase-like kinases. Cellular inhibition of ATM by KU-55933 was demonstrated by the ablation of ionizing radiation-dependent phosphorylation of a range of ATM targets, including p53, gammaH2AX, NBS1, and SMC1. KU-55933 did not show inhibition of UV light DNA damage induced cellular phosphorylation events. Exposure of cells to KU-55933 resulted in a significant sensitization to the cytotoxic effects of ionizing radiation and to the DNA double-strand break-inducing chemotherapeutic agents, etoposide, doxorubicin, and camptothecin. Inhibition of ATM by KU-55933 also caused a loss of ionizing radiation-induced cell cycle arrest. By contrast, KU-55933 did not potentiate the cytotoxic effects of ionizing radiation on ataxia-telangiectasia cells, nor did it affect their cell cycle profile after DNA damage. We conclude that KU-55933 is a novel, specific, and potent inhibitor of the ATM kinase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The translocation of USP10 could be blocked by the ATM inhibitor Ku55933”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Hickson et al., 2004
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,248
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks
Burma, S., Chen, B. P., Murphy, M., Kurimasa, A., & Chen, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100466200 · Cited by 1,954
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
Walker, E. H., Pacold, M. E., Perišić, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00089-4 · Cited by 1,211
ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation
Stiff, T., O’Driscoll, M., Rief, N., Iwabuchi, K., Löbrich, M., & Jeggo, P. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3207 · Cited by 1,050
Research works printed but not linked: 1
- Ormerod MG Analysis of DNA-general methods Ormerod MG eds. . Flow cytometry 200083-97. Oxford University Press Oxford, UK
Cited by
Sorted by citations
Items 401–500 of 1,000
Schweikl, H., Petzel, C., Bolay, C., Hiller, K., Buchalla, W., & Krifka, S. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.044 · Cited by 64
ATM/ATR‐mediated phosphorylation of PALB2 promotes RAD51 function
Ahlskog, J. K., Larsen, B. D., Achanta, K., & Sørensen, C. S. (2016) · EMBO Reports · doi:10.15252/embr.201541455 · Cited by 64
Finzel, A., Grybowski, A., Strasen, J., Cristiano, E., & Loewer, A. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-01-0032 · Cited by 65
Vara‐Ciruelos, D., Dandapani, M., Gray, A., Egbani, E. O., Evans, A. M., & Hardie, D. G. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0323 · Cited by 64
Single-nucleosome imaging reveals steady-state motion of interphase chromatin in living human cells
Iida, S., Shinkai, S., Itoh, Y., Tamura, S., Kanemaki, M. T., Onami, S., & Maeshima, K. (2022) · Science Advances · doi:10.1126/sciadv.abn5626 · Cited by 64
Cytotoxic Effects of Temozolomide and Radiation are Additive- and Schedule-Dependent
Chalmers, A. J., Ruff, E. M., Martindale, C. A., Lovegrove, N., & Short, S. C. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.07.1703 · Cited by 65
Close Proximity to Igh Is a Contributing Factor to AID-Mediated Translocations
Rocha, P. P., Micsinai, M., Kim, J., Hewitt, S. L., Souza, P. P., Trimarchi, T., Strino, F., Parisi, F., Kluger, Y., & Skok, J. A. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.06.036 · Cited by 63
Recruitment and activation of the ATM kinase in the absence of DNA-damage sensors
Hartlerode, A. J., Morgan, M. J., Wu, Y., Buis, J. M., & Ferguson, D. O. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3072 · Cited by 69
Green, A. M., Budagyan, K., Hayer, K. E., Reed, M. A., Savani, M. R., Wertheim, G. B. W., & Weitzman, M. D. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3394 · Cited by 63
Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors
Sengupta, S., Sobo, M., Lee, K., Kumar, S. S., White, A. R., Mender, I., Fuller, C. E., Chow, L. M. L., Fouladi, M., Shay, J. W., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0792 · Cited by 61
Erratum: ATM-mediated KDM2A phosphorylation is required for the DNA damage repair
Cao, L.-L., Wei, F., Du, Y., Song, B., Wang, D., Shen, C., Lu, X., Cao, Z., Yang, Q., Gao, Y., et al. (2016) · Oncogene · doi:10.1038/onc.2015.311 · Cited by 63
Self-citationFreije, A., Molinuevo, R., Ceballos, L., Cagigas, M., Alonso‐Lecue, P., Rodrı́guez, R., Menéndez, P. R., Aberdam, D., de Diego, E., & Gandarillas, A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.012 · Cited by 62
Inhibition of ATM kinase activity does not phenocopy ATM protein disruption
Choi, S., Gamper, A. M., White, J. S., & Bakkenist, C. J. (2010) · Cell Cycle · doi:10.4161/cc.9.20.13471 · Cited by 68
Beretta, G. L., Perego, P., & Zunino, F. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.10.1243 · Cited by 62
ATM and ATR Activities Maintain Replication Fork Integrity during SV40 Chromatin Replication
Sowd, G. A., Li, N. Y., & Fanning, E. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003283 · Cited by 63
Eliezer, Y., Argaman, L., Kornowski, M., Roniger, M., & Goldberg, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532739 · Cited by 68
Targeting DNA repair pathways: A novel approach to reduce cancer therapeutic resistance
Zhu, Y.-J., Hu, J., Hu, Y., & Liu, W. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.06.005 · Cited by 67
Pneumococcal Pneumolysin Induces DNA Damage and Cell Cycle Arrest
Rai, P., He, F., Kwang, J., Engelward, B. P., & Chow, V. T. K. (2016) · Scientific Reports · doi:10.1038/srep22972 · Cited by 65
Fernández‐Aroca, D. M., Roche, O., Sabater, S., Pascual‐Serra, R., Ortega‐Muelas, M., Sánchez‐Pérez, I., Belandia, B., Ruiz‐Hidalgo, M. J., & Sánchez‐Prieto, R. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.049 · Cited by 60
An ATM- and ATR-dependent checkpoint inactivates spindle assembly by targeting CEP63
Smith, E., Dejsuphong, D., Balestrini, A., Hampel, M., Lenz, C., Takeda, S., Vindigni, A., & Costanzo, V. (2009) · Nature Cell Biology · doi:10.1038/ncb1835 · Cited by 64
Targeting abnormal DNA double strand break repair in cancer
Rassool, F. V., & Tomkinson, A. E. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0493-5 · Cited by 62
Zhang, L., Cheng, X. F., Gao, Y., Bao, J., Guan, H., Lu, R., Yu, H., Xu, Q., & Sun, Y. (2015) · Food & Function · doi:10.1039/c5fo00681c · Cited by 63
Cowell, I. G., Durkacz, B. W., & Tilby, M. J. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.029 · Cited by 61
Gutierrez-Martinez, P., Hogdal, L., Nagai, M., Kruta, M., Singh, R., Sarosiek, K., Nussenzweig, A., Beerman, I., Letai, A., & Rossi, D. J. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0054-y · Cited by 60
ATM-independent, high-fidelity nonhomologous end joining predominates in human embryonic stem cells
Adams, B. R., Hawkins, A. J., Povirk, L. F., & Valerie, K. C. (2010) · Aging · doi:10.18632/aging.100197 · Cited by 60
Nakamura, K., Karmokar, A., Farrington, P. M., James, N. H., Ramos‐Montoya, A., Bickerton, S. J., Hughes, G. D., Illidge, T., Cadogan, E. B., Davies, B. R., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3701 · Cited by 60
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome
Boehrer, S., Adès, L., Tajeddine, N., Hofmann, W.-K., Kriener, S., Bug, G., Ottmann, O. G., Ruthardt, M., Galluzzi, L., Fouassier, C., et al. (2009) · Oncogene · doi:10.1038/onc.2009.69 · Cited by 62
Burdak‐Rothkamm, S., & Prise, K. M. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.068 · Cited by 60
Benhelli‐Mokrani, H., Gaillard, L., Biasutto, P., Guen, T. L., Touzot, F., Vasquez, N., Komatsu, J., Conseiller, E., Pïcard, C., Gluckman, É., et al. (2012) · Human Mutation · doi:10.1002/humu.22245 · Cited by 66
Rashi‐Elkeles, S., Warnatz, H.-J., Elkon, R., Kupershtein, A., Chobod, Y., Paz, A., Amstislavskiy, V. S., Sultan, M., Safer, H. M., Nietfeld, W., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005032 · Cited by 57
Korwek, Z., Sewastianik, T., Bielak-Żmijewska, A., Mosieniak, G., Alster, O., Moreno-Villaneuva, M., Bürkle, A., & Sikora, E. (2012) · DNA repair · doi:10.1016/j.dnarep.2012.08.006 · Cited by 60
Mechanisms of DNA damage repair in adult stem cells and implications for cancer formation
Weeden, C. E., & Asselin-Labat, M.-L. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.015 · Cited by 61
Synthetic Lethality through the Lens of Medicinal Chemistry
Myers, S. H., Ortega, J. A., & Cavalli, A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00766 · Cited by 63
Cruet-Hennequart, S., Glynn, M. T., Murillo, L. S., Coyne, S., & Carty, M. P. (2008) · DNA repair · doi:10.1016/j.dnarep.2007.12.012 · Cited by 60
Zimmermann, A., Zenke, F. T., Chiu, L.-Y., Dahmen, H., Pehl, U., Fuchß, T., Grombacher, T., Blume, B., Vassilev, L. T., & Blaukat, A. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0934 · Cited by 60
Zimmermann, M., Don, A. S. A., Donaldson, M. S., Dallapiazza, R. F., Cowan, C. E., & Horne, M. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.376855 · Cited by 63
Hau, P. M., Deng, W., Jia, L., Yang, J., Tsurumi, T., Chiang, A., Huen, M. S. Y., & Tsao, S. W. (2014) · Journal of Virology · doi:10.1128/jvi.01437-14 · Cited by 61
Segal, H., Mass, G., Baranes‐Bachar, K., Lerenthal, Y., Wang, S., Chung, Y. M., Ziv‐Lehrman, S., Ström, C. E., Helleday, T., Hu, M. C. ‐., et al. (2011) · EMBO Reports · doi:10.1038/embor.2011.96 · Cited by 58
Sears, C. R., Cooney, S. A., Chin-Sinex, H., Mendonca, M. S., & Turchi, J. J. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.02.004 · Cited by 60
Zhang, W., Chen, Z., Zhang, D., Zhao, B., Liu, L., Xie, Z., Yao, Y., & Zheng, P. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000468 · Cited by 59
Laprade, H., Querido, E., Smith, M. J., Guérit, D., Crimmins, H., Conomos, D., Pourret, E., Chartrand, P., & Sfeir, A. J. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.005 · Cited by 58
Britton, S., Chanut, P., Delteil, C., Barboule, N., Frit, P., & Calsou, P. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa723 · Cited by 65
The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect
Zhang, T., Shen, Y., Chen, Y., Hsieh, J., & Kong, Z. (2015) · International Journal of Radiation Biology · doi:10.3109/09553002.2015.1001531 · Cited by 58
Surovtseva, Y. V., Jairam, V., Salem, A. F., Sundaram, R. K., Bindra, R. S., & Herzon, S. B. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b00162 · Cited by 58
Moumen, A., Magill, C. P., Dry, K. L., & Jackson, S. P. (2013) · Cell Cycle · doi:10.4161/cc.23592 · Cited by 60
Self-citationRole of GLUT1 in regulation of reactive oxygen species
Andrisse, S., Koehler, R. M., Chen, J. E., Patel, G. D., Vallurupalli, V., Ratliff, B. A., Warren, D. E., & Fisher, J. S. (2014) · Redox Biology · doi:10.1016/j.redox.2014.03.004 · Cited by 58
Targeting the DNA Double Strand Break Repair Machinery in Prostate Cancer
Shaheen, F. S., Znojek, P., Fisher, A. M., Webster, M., Plummer, R., Gaughan, L., Smith, G. C. M., Leung, H. Y., Curtin, N. J., & Robson, C. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020311 · Cited by 60
Self-citationProspects for the Use of ATR Inhibitors to Treat Cancer
Wagner, J. M., & Kaufmann, S. H. (2010) · Pharmaceuticals · doi:10.3390/ph3051311 · Cited by 57
Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia
Tomic, J., Lichty, B. D., & Spaner, D. (2011) · Blood · doi:10.1182/blood-2010-05-285999 · Cited by 57
‘How can I halt thee?’ The puzzles involved in autophagic inhibition
Vinod, V., Padmakrishnan, C. J., Vijayan, B., & Gopala, S. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.03.005 · Cited by 61
Singh, V. V., Dutta, D., Ansari, M. A., Dutta, S., & Chandran, B. (2013) · Journal of Virology · doi:10.1128/jvi.03126-13 · Cited by 56
The kinetochore protein Bub1 participates in the DNA damage response
Yang, C., Wang, H., Xu, Y., Brinkman, K. L., Ishiyama, H., Wong, S. T. C., & Xu, B. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.10.018 · Cited by 56
Ding, D., Zhang, Y., Wang, J., Zhang, X., Gao, Y., Yin, L., Li, Q.-R., Li, J., & Chen, H. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.11 · Cited by 59
The DNA-damage response: new molecular insights and new approaches to cancer therapy
Jackson, S. P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370483 · Cited by 59
Self-citationAi, L., Skehan, R. R., Saydi, J., Lin, T., & Brown, K. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.339317 · Cited by 55
Chk2 is required for HSV-1 ICP0-mediated G2/M arrest and enhancement of virus growth
Han, L., Rajasekaran, B., Krisky, D. M., Bein, K., Grandi, P., Cohen, J. B., & Glorioso, J. C. (2008) · Virology · doi:10.1016/j.virol.2008.01.038 · Cited by 56
Menear, K. A., Gomez, S., Malagu, K., Bailey, C., Blackburn, K., Cockcroft, X. F., Ewen, S., Fundo, A., Gall, A. L., Hermann, G., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.069 · Cited by 57
Self-citationMacůrek, L., Benada, J., Müllers, E., Halim, V. A., Krejčíková, K., Burdová, K., Pecháčková, S., Hodný, Z., Lindqvist, A., Medema, R. H., et al. (2013) · Cell Cycle · doi:10.4161/cc.23057 · Cited by 56
Cristini, A., Park, J.-H., Capranico, G., Legube, G., Favre, G., & Sordet, O. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1196 · Cited by 60
Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinoma
Zhou, L., Zhang, T., Xue, Y., Yue, C., Pan, Y., Wang, P., Yang, T., Li, M., Zhou, H., Ding, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42784-4 · Cited by 54
Rein, I. D., Landsverk, K. S., Micci, F., Patzke, S., & Stokke, T. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1085137 · Cited by 54
Jowsey, P. A., Williams, F. M., & Blain, P. G. (2008) · Toxicology · doi:10.1016/j.tox.2008.12.001 · Cited by 54
On the Path to Seeking Novel Radiosensitizers
Katz, D., Ito, E., & Liu, F. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.12.002 · Cited by 56
DNA damage-induced inhibition of rRNA synthesis by DNA-PK and PARP-1
Calkins, A. S., Iglehart, J. D., & Lazaro, J. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt502 · Cited by 54
Tamakawa, R., Fleisig, H. B., & Wong, J. M. Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2227 · Cited by 53
Alao, J. P., & Sunnerhagen, P. (2009) · Radiation Oncology · doi:10.1186/1748-717x-4-51 · Cited by 55
Quantitative Chemical Proteomic Profiling of Ubiquitin Specific Proteases in Intact Cancer Cells
Ward, J., McLellan, L., Stockley, M. L., Gibson, K. R., Whitlock, G. A., Knights, C., Harrigan, J. A., Jacq, X., & Tate, E. W. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00766 · Cited by 54
Masamsetti, V. P., Low, R. R. J., Mak, K. S., O’Connor, A., Riffkin, C. D., Lamm, N., Crabbé, L., Karlseder, J., Huang, D. C. S., Hayashi, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12255-w · Cited by 56
Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage
Merolla, F., Pentimalli, F., Pacelli, R., Vecchio, G., Fusco, A., Grieco, M., & Celetti, A. (2007) · Oncogene · doi:10.1038/sj.onc.1210446 · Cited by 54
ATM-mediated phosphorylation activates the tumor-suppressive function of B56γ–PP2A
Shouse, G., Nobumori, Y., Panowicz, M. J., & Liu, X. (2011) · Oncogene · doi:10.1038/onc.2011.95 · Cited by 53
Baculovirus Infection Induces a DNA Damage Response That Is Required for Efficient Viral Replication
Huang, N., Wu, W., Yang, K., Passarelli, A. L., Rohrmann, G. F., & Clem, R. J. (2011) · Journal of Virology · doi:10.1128/jvi.05766-11 · Cited by 53
Synergistic gene editing in human iPS cells via cell cycle and DNA repair modulation
Maurissen, T. L., & Woltjen, K. (2020) · Nature Communications · doi:10.1038/s41467-020-16643-5 · Cited by 54
Di Virgilio, M., Ying, C. Y., & Gautier, J. (2009) · DNA Repair · doi:10.1016/j.dnarep.2009.07.006 · Cited by 52
A single synonymous mutation determines the phosphorylation and stability of the nascent protein
Karakostis, K., Gnanasundram, S. V., López, I., Thermou, A., Wang, L., Nylander, K., Olivares‐Illana, V., & Fåhræus, R. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy049 · Cited by 54
Yamaguchi, M., Fujimori-Tonou, N., Yoshimura, Y., Kishi, T., Okamoto, H., & Masai, I. (2008) · Development · doi:10.1242/dev.011015 · Cited by 51
Molecular Targets for Tumor Radiosensitization
Tofilon, P. J., & Camphausen, K. A. (2009) · Chemical Reviews · doi:10.1021/cr800504x · Cited by 51
ATM–Dependent MiR-335 Targets CtIP and Modulates the DNA Damage Response
Martin, N. T., Nakamura, K., Davies, R. C., Nahas, S., Brown, C., Tunuguntla, R., Gatti, R. A., & Hu, H. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003505 · Cited by 50
Self-citationColin, D., Hain, K. O., Allan, L. A., & Clarke, P. R. (2015) · Open Biology · doi:10.1098/rsob.140156 · Cited by 50
Clinical potential of ATM inhibitors
Lavin, M. F., & Yeo, A. J. (2020) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2020.111695 · Cited by 51
Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy
Matsumoto, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084264 · Cited by 50
Huang, Y., Sen, T., Nagpal, J. K., Upadhyay, S. K., Trink, B., Ratovitski, E. A., & Sidransky, D. (2008) · Cell Cycle · doi:10.4161/cc.7.18.6627 · Cited by 49
He, L., Nan, M.-H., Oh, H. C., Kim, Y. H., Jang, J. H., Erikson, R. L., Ahn, J. S., & Kim, B. Y. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.032 · Cited by 50
A Novel Role for hSMG-1 in Stress Granule Formation
Brown, J. A. L., Roberts, T. L., Richards, R. S., Woods, R. G., Birrell, G. W., Lim, Y. C., Ohno, S., Yamashita, A., Abraham, R. T., Gueven, N., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05987-11 · Cited by 50
As a Nucleus Enters a Small Pore, Chromatin Stretches and Maintains Integrity, Even with DNA Breaks
Irianto, J., Xia, Y., Pfeifer, C. R., Greenberg, R. A., & Discher, D. E. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.09.047 · Cited by 49
Molecular avenues in targeted doxorubicin cancer therapy
Roychoudhury, S., Kumar, A., Bhatkar, D., & Sharma, N. K. (2020) · Future Oncology · doi:10.2217/fon-2019-0458 · Cited by 49
DNA-PK in human malignant disorders: Mechanisms and implications for pharmacological interventions
Medová, M., Medo, M., Hovhannisyan, L., Muñoz-Maldonado, C., Aebersold, D. M., & Zimmer, Y. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107617 · Cited by 48
Nuclear UHRF1 is a gate-keeper of cellular AMPK activity and function
Xu, X., Ding, G., Liu, C., Ding, Y., Chen, X. L., Huang, X., Zhang, C., Lu, S., Zhang, Y., Huang, Y., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00565-y · Cited by 47
Hak, C. C. W., Rullan, A., Patin, E. C., Pedersen, M., Melcher, A. A., & Harrington, K. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.971959 · Cited by 50
Fernandes, N. D., Sun, Y., & Price, B. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609628200 · Cited by 48
Verschuren, E. W., Ban, K. H.-K., Masek, M. A., Lehman, N. L., & Jackson, P. K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00908-07 · Cited by 52
Bian, L., Meng, Y., Zhang, M., Guo, Z., Liu, F.-R., Zhang, W., Xue, K., Su, Y., Wang, M., Yao Zong, Y. U. A. N., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.41246 · Cited by 47
The Breast Cancer Susceptibility Gene BRCA2 Is Required for the Maintenance of Telomere Homeostasis
Min, J., Choi, E. S., Hwang, K., Kim, J., Sampath, S. C., Venkitaraman, A. R., & Lee, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.278994 · Cited by 47
CDK 4/6 inhibitors combined with radiotherapy: A review of literature
Bosacki, C., Bouleftour, W., Sotton, S., Vallard, A., Daguenet, É., Ouaz, H., Cojocaru, I., Moslemi, D., Malekzadeh, M., & Magné, N. (2020) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2020.11.010 · Cited by 48
ATM-Dependent Hyper-Radiosensitivity in Mammalian Cells Irradiated by Heavy Ions
Xue, L., Yu, D. S., Furusawa, Y., Cao, J., Okayasu, R., & Fan, S. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.088 · Cited by 47
Köcher, S., Rieckmann, T., Rohaly, G., Mansour, W. Y., Dikomey, E., Dornreiter, I., & Dahm‐Daphi, J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks604 · Cited by 49
p53 Prevents Entry into Mitosis with Uncapped Telomeres
Thanasoula, M., Escandell, J. M., Martínez, P., Badie, S., Muñoz, P., Blasco, M. A., & Tarsounas, M. (2010) · Current Biology · doi:10.1016/j.cub.2010.01.046 · Cited by 49
ATM-mediated response to DNA double strand breaks in human neurons derived from stem cells
Biton, S., Gropp, M., Itsykson, P., Pereg, Y., Mittelman, L. A., Johe, K. K., Reubinoff, B. E., & Shiloh, Y. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.10.019 · Cited by 48
Mukherjee, B., Choy, H., Nirodi, C. S., & Burma, S. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.05.002 · Cited by 48
Higuchi, F., Fink, A. L., Kiyokawa, J., Miller, J. J., Koerner, M. V. A., Cahill, D. P., & Wakimoto, H. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0177 · Cited by 46
Duskova, K., Lejault, P., Benchimol, É., Guillot, R., Britton, S., Granzhan, A., & Monchaud, D. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b11150 · Cited by 46
Metadata
- Authors
- Hickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., & Smith, G. C. M.
- Affiliations
- 1KuDOS Pharmaceuticals Ltd., Cambridge Science Park, Milton Road, Cambridge;
- Newcastle University (GB)
- University of Cambridge (GB)
- ORCID
- Venue
- Cancer Research
- Published
- 2004-12-15
- Volume
- 64
- Issue
- 24
- Pages
- 9152-9159
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2101988823
- Cited by
- 1,220
- References
- 58
- Citations by year
- 2026: 26 · 2025: 31 · 2024: 38 · 2023: 49 · 2022: 31 · 2021: 32 · 2020: 53 · 2019: 55 · 2018: 48 · 2017: 66 · 2016: 71 · 2015: 76 · 2014: 70 · 2013: 62 · 2012: 92
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- ATM kinase, KU55933, kinase inhibitors, ataxia telangiectasia, radiosensitivity, DNA double-strand breaks, cell cycle arrest, p53 phosphorylation, NBS1, radiosensitization, chemosensitization, etoposide, doxorubicin, camptothecin, γH2AX, SMC1A
- MeSH terms
- Cell Cycle, Chromones, DNA-Binding Proteins, HeLa Cells, Humans, Kinetics, Morpholines, Phosphorylation, Pyrones, Radiation-Sensitizing Agents, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Inhibitory Concentration 50, Combinatorial Chemistry Techniques, Tumor Suppressor Proteins, Cell Line, Tumor, Protein Kinase Inhibitors, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review